Completed OBSERVATIONAL NCT01666106

Osteonecrosis of the Jaw (ONJ) Case Registry

Sponsor: Amgen

Updated 12 times since 2017 Last updated: Dec 18, 2020 Started: Oct 1, 2012 Primary completion: Dec 16, 2020 Completion: Dec 16, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01666106, this observational or N/A phase trial focuses on Osteonecrosis of the Jaw and remains completed. Sponsored by Amgen, it has been updated 12 times since 2012, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

12 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed

Status: Active Not Recruiting → Completed
Dec 2020 — Jan 2021 [monthly]

Active Not Recruiting

▶ Show 7 earlier versions

Nov 2019 — Dec 2020 [monthly]

Active Not Recruiting
Nov 2018 — Nov 2019 [monthly]

Active Not Recruiting
Jun 2018 — Nov 2018 [monthly]

Active Not Recruiting
Apr 2018 — Jun 2018 [monthly]

Active Not Recruiting

Phase: NA → None
Dec 2017 — Apr 2018 [monthly]

Active Not Recruiting NA
Jul 2017 — Dec 2017 [monthly]

Active Not Recruiting NA
Jan 2017 — Jul 2017 [monthly]

Active Not Recruiting NA

First recorded

Oct 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Amgen

Data source: Amgen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aarhus C, Denmark , Alessandria, Italy , Athens, Greece , Atlanta, United States , Baltimore, United States , Barcelona, Spain , Berlin, Germany , Beverly Hills, United States , Bordeaux, France , Brescia, Italy and 47 more locations